Dr Lal Pathlabs Ltd vs Shalby Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Dr Lal Pathlabs Ltd is ₹ 1845 as of 23 Oct 15:30 . The P/E Ratio of Dr Lal Pathlabs Ltd changed from 77.4 on March 2021 to 43.6 on March 2026 . This represents a CAGR of -9.12% over 6 yearsThe P/E Ratio of Shalby Ltd changed from 25.7 on March 2021 to 36.5 on March 2026 . This represents a CAGR of 6.02% over 6 years The Market Cap of Dr Lal Pathlabs Ltd changed from ₹ 22565 crore on March 2021 to ₹ 22015 crore on March 2026 . This represents a CAGR of -0.41% over 6 yearsThe Market Cap of Shalby Ltd changed from ₹ 1089 crore on March 2021 to ₹ 1370 crore on March 2026 . This represents a CAGR of 3.90% over 6 years The revenue of Dr Lal Pathlabs Ltd for the Jun '26 is ₹ 829.6 crore as compare to the Mar '26 revenue of ₹ 726.7 crore. This represent the growth of 14.16% The revenue of Shalby Ltd for the Jun '26 is ₹ 338.64 crore as compare to the Mar '26 revenue of ₹ 295.52 crore. This represent the growth of 14.59% The ebitda of Dr Lal Pathlabs Ltd for the Jun '26 is ₹ 279.4 crore as compare to the Mar '26 ebitda of ₹ 210.8 crore. This represent the growth of 32.54% The ebitda of Shalby Ltd for the Jun '26 is ₹ 49 crore as compare to the Mar '26 ebitda of ₹ 37.43 crore. This represent the growth of 30.91% The net profit of Dr Lal Pathlabs Ltd changed from ₹ 107.8 crore to ₹ 170.5 crore over 9 quarters. This represents a CAGR of 22.60% The net profit of Shalby Ltd changed from ₹ 14.74 crore to ₹ 10.5 crore over 9 quarters. This represents a CAGR of -13.99% The Dividend Payout of Dr Lal Pathlabs Ltd changed from 59.51 % on March 2021 to 67.59 % on March 2026 . This represents a CAGR of 2.14% over 6 yearsThe Dividend Payout of Shalby Ltd changed from 25.19 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 years .

About Dr Lal Pathlabs Ltd

Dr. Lal PathLabs Limited was incorporated as a Private Limited Company with the name Dr. Lal PathLabs Private Limited', on February 14, 1995 at Delhi.
The business of the Partnership Firm, Central Clinical Laboratory was undertaken by the Company.
The Company converted into a Public Limited Company and name of the Company was changed to Dr. Lal PathLabs Limited' vide fresh Certificate of Incorporation granted by the RoC on August 19, 2015. Dr Lal PathLabs is among the most trusted diagnostic healthcare service provider in India, offering services through over 5000 diagnostic tests and related healthcare services through a nationwide network of medical laboratory centres.
Through its integrated, nationwide network, the Company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Shalby Ltd

Shalby Limited was originally incorporated as a Private Limited Company with the name 'Shalby Hospital Private Limited' on August 30, 2004.
Subsequently, the Company was converted to a Public Limited Company and the name was changed to 'Shalby Hospital Public Limited' on May 15, 2006.
Further, the name of the Company was changed to Shalby Hospitals Limited on July 26, 2006 and then, again changed to Shalby Limited on February 13, 2008. Shalby Limited is an Ahmedabad-headquartered and one of the leading multi-specialty chain of hospitals in India and provides high-quality and economical healthcare services.
With 15 hospitals and over 2,300 beds across 12 cities, Shalby is now the largest corporate hospital group in Western and Central India.
The Hospitals are tertiary care hospitals, few of which offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations.

FAQs for the comparison of Dr Lal Pathlabs Ltd and Shalby Ltd

Which company has a larger market capitalization, Dr Lal Pathlabs Ltd or Shalby Ltd?

Market cap of Dr Lal Pathlabs Ltd is 30,977 Cr while Market cap of Shalby Ltd is 1,227 Cr

What are the key factors driving the stock performance of Dr Lal Pathlabs Ltd and Shalby Ltd?

The stock performance of Dr Lal Pathlabs Ltd and Shalby Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lal Pathlabs Ltd and Shalby Ltd?

As of October 25, 2026, the Dr Lal Pathlabs Ltd stock price is INR ₹1845.55. On the other hand, Shalby Ltd stock price is INR ₹113.65.

How do dividend payouts of Dr Lal Pathlabs Ltd and Shalby Ltd compare?

To compare the dividend payouts of Dr Lal Pathlabs Ltd and Shalby Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.